4.8 Article

RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity

Journal

SCIENCE ADVANCES
Volume 6, Issue 22, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aaz3865

Keywords

-

Funding

  1. NIH [R01CA188419, R01AI070603, P01CA186866]
  2. American Cancer Society Intra-institutional Grant [129806-IRG16-185-17-IRG]
  3. Flow Cytometry & Cell Sorting Shared Resource Unit at the OSU and Hollings Cancer Center
  4. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Distinct lineages of T cells can act in response to various environmental cues to either drive or restrict immune-mediated pathology. Here, we identify the RNA binding protein, poly(C)-binding protein 1 (PCBP1) as an intracellular immune checkpoint that is up-regulated in activated T cells to prevent conversion of effector T (T-eff) cells into regulatory T (T-reg) cells, by restricting the expression of T-eff cell-intrinsic T-reg commitment programs. This was critical for stabilizing T-eff cell functions and subverting immune-suppressive signals. T cell-specific deletion of Pcbp1 favored T-reg cell differentiation, enlisted multiple inhibitory immune checkpoint molecules including PD-1, TIGIT, and VISTA on tumor-infiltrating lymphocytes, and blunted antitumor immunity. Our results demonstrate a critical role for PCBP1 as an intracellular immune checkpoint for maintaining T-eff cell functions in cancer immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available